For Research Purposes Only. Not approved for human consumption.
Hexarelin Research Peptide
Hexarelin is a synthetic hexapeptide and one of the most potent GHRPs studied in research. As a ghrelin mimetic it binds GHS-R1a receptors to stimulate GH release. Uniquely among GHRPs, Hexarelin also directly binds CD36 receptors on cardiomyocytes, producing cardioprotective effects independent of GH. This dual mechanism makes it valuable for research spanning both metabolic GH biology and cardiac physiology.
Research Applications
- Potent GH secretagogue studies
- Ghrelin receptor (GHS-R1a) biology
- Cardioprotection and cardiomyocyte research (CD36)
- Hypothalamic-pituitary axis investigations
- Combination secretagogue protocols with GHRH analogs
Quality Specifications
- Purity: ≥98% (HPLC verified)
- Compound: Hexarelin
- Molecular Weight: 887.05 Da
- Form: Lyophilized powder
- Storage: -20°C, protect from light
- COA: Batch-specific, ISO-accredited laboratory
Frequently Asked Questions
Q: How does Hexarelin compare to other GHRPs?
A: Generally among the most potent GHRPs for GH release. Also has unique cardioprotective effects via CD36 binding not shared by Ipamorelin or GHRP-6.
Q: What is the CD36 receptor?
A: A scavenger receptor expressed in cardiomyocytes, adipocytes, and macrophages. Hexarelin’s CD36 binding in cardiac tissue produces cardioprotective effects in research models independent of GH release.
Q: Can Hexarelin be combined with GHRH analogs?
A: Yes. Hexarelin (ghrelin receptor) + CJC-1295 (GHRH receptor) targets two independent GH release pathways for synergistic effects.
Related Research: Ipamorelin | CJC-1295 No DAC | Sermorelin
For laboratory research use only. Not for human consumption. Not evaluated by the FDA.
Reviews
Clear filtersThere are no reviews yet.